Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Incyte Announces Acquisition of Escient Pharmaceuticals and its Pipeline of First-in-Class Oral MRGPR Antagonists
Read Article
News
2024
2023
Archive
Search news articles
July 28, 2020
Cleave Therapeutics Announces Commencement of a Phase I Clinical Study of CB-5339, A Valosin-Containing Protein (VCP)/p97 Inhibitor, in Patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
July 27, 2020
scPharmaceuticals Announces FDA Acceptance of FUROSCIX® New Drug Application Resubmission
July 22, 2020
Nouscom Highlights Cutting-Edge Science That Led to the Design of NOUS-209, A Potential Off-The-Shelf Neoantigen Cancer Vaccine for Tumors with Microsatellite Instability
July 22, 2020
Homology Medicines Appoints Jeff Poulton to the Board of Directors
July 17, 2020
Vor Biopharma Appoints Daniella Beckman to its Board of Directors
July 17, 2020
IDEAYA Announces IDE196 Program Update and Clinical Protocol Criteria Met for Cohort Expansion in Skin Melanoma for Phase 2 GNAQ/11 Basket Trial
July 16, 2020
RareCyte® Announces the Orion™ Spatial Biology Platform with Breakthrough Technology for Same-Day Highly Multiplexed Tissue Analysis
July 16, 2020
Aprea Therapeutics Announces Expansion of Clinical Trial Evaluating Eprenetapopt for the Front-Line Treatment of TP53 Mutant Acute Myeloid Leukemia (AML)
July 15, 2020
Vor Biopharma Appoints Dr. Christopher Slapak as Chief Medical Officer
July 14, 2020
Pear Therapeutics Announces First Participant Enrolled in Virtual Real-World Study of Adults with Chronic Insomnia
« Previous Page
1
…
5
6
7
8
9
…
14
Next Page »